Pre-emptive vaccination against pandemic influenza virus

Vaccine

Volumn 25, Issue 11, 2007, Pages 1921-1922

  Montomoli, Emanuele ^a   Manini, Ilaria ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Pandemic influenza vaccination; Pandemic preparedness

Indexed keywords

ADAMANTANE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR;

AVIAN INFLUENZA; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EPIDEMIC; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; LETTER; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; VIRUS RESISTANCE;

DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; ORTHOMYXOVIRIDAE;

EID: 33846882357     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.026     Document Type: Letter

References (13)

1. Glezen W.P. Emerging infections: pandemic influenza. Epidemiol Rev 18 (1996) 64-76
2. Li K.S., Guan Y., Wang J., Smith G.J., Xu K.M., Duan L., et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430 6996 (2004) 209-213
3. World Health Organization. Epidemiology of WHO-confirmed human cases of avian influenza A (H5N1) infection. Wkly Epidemiol Rec 81 26 (2006) 249-257
4. Bartlett J.G. Planning for avian influenza. Ann Intern Med 145 2 (2006) 141-144
5. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353 (2005) 2667-2672
6. Larkin M. Avian flu: sites seek to respond and reassure. Lancet Infect Dis 5 3 (2005) 141-142
7. Nguyen-Van-Tam J.S., and Hampson A.W. The epidemiology and clinical impact of pandemic influenza. Vaccine 21 16 (2003) 1762-1768
8. Barnitz L., Berkwits M., and American College of Physicians. The health care response to pandemic influenza. Ann Intern Med 145 2 (2006) 135-137
9. Gaydos J.C., Top Jr. F.H., Hodder R.A., and Russell P.K. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 12 1 (2006) 23-28
10. Sencer D.J., and Donald Millar J. Reflections on the 1976 Swine Flu Vaccination Program. Emerg Infect Dis 12 1 (2006) 29-33
11. Emanuel E.J., and Wertheimer A. Public health. Who should get influenza vaccine when not all can?. Science 312 5775 (2006) 854-855
12. Temte J.L. Preparing for an influenza pandemic: vaccine prioritization. Fam Pract Manag 13 1 (2006) 32-34
13. Del Giudice G., Hilbert A.K., Bugarini R., Minutello A., Popova O., Toneatto D., et al. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. Vaccine 24 16 (2006) 3063-3065